US FDA Launches Rare Disease Drug Development Initiative

To solicit feedback on the Rare Disease Framework Initiative from patients and disease advocates, industry, and others, the FDA will host a meeting at the FDA’s White Oak campus. The meeting will be facilitated by the Reagan-Udall Foundation for the FDA.

Read more.